Preimplantation genetic diagnosis

	Preimplantation genetic diagnosis (PGD) was developed in Britain in the mid-eighties as a way to test human embryos (created through IVF) for genetic abnormalities prior to transferring them to the mother, with an introductory commentary by Senior Fellow Dr. Chris Oleson.

News, Background & Statistics, Commentary

Study: Genetic Diagnosis Reduces Births
L.A. Times

Genetic Screening Fails Women Trying
for IVF Birth
Reuters

"Designer" Babies with Made-to-Order Defects? Prenatal testing creates controversial options for parents with disabilities - Associated Press

Study Questions Success of Pregnancy Technique
NPR


Background and Statistics

Genetic Testing of Embryos: Practices and Perspectives
Genetics and Public Policy Center

Preimplantation Genetic Diagnosis: Public Policy and Public Attitudes
Genetics and Public Policy Center

U.K. Human Fertilisation and Embryology Authority (HFEA) list of conditions licensed to be screened through PGD

European Society of Human Reproduction and Embryology (ESHRE) PGD Consortium Data

European Society of Human Reproduction and Embryology (ESHRE) Guidelines

Commentary

Poor Prognosis for Preimplantation Genetic Diagnosis (PGD)?
John Kilner, PhD, Center for Bioethics
and Human Dignity

Social and Ethical Challenges of Prenatal Diagnosis
Medical Ethics

Forward to a friend

Subscribe to e-column

Send Response

Back to Top